Valeo Pharma Inc VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

GREY:VPHIF - Post by User

Valeo Pharma Inc > Summer slow down

<< Previous

Bullboard Posts

Next >>

Comment by kooter33on Jun 18, 2021 3:26pm

147 Views

Post# 33412540

RE:Summer slow down

JACKTHEBEAR2 wrote: I think we are witnessing the summer slow down sell all specs period and only a nice revenue boost release will get us back on track. It will come.

Agreed, get this damn bought deal closed and the release of the Q2 report, then the Montreal Heart Institute report sometime in July, this stock should be on track to hit Paradigm's target of $ 3.50 especially since they are one of the underwriters for this deal. The other is Desjardins.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity